Key facts
as of Sep 2026- Resonant Link Medical’s last known valuation is $19.5M (Apr 2025).
- It has raised $3.4M across 1 recorded rounds; the latest was Seed Round ($3.4M) in Dec 2024.
- Notable investors include VXI Capital Management, Kaleida Capital, Features Capital, VCET Capital.
- 1 institutional filer reports fund marks on Resonant Link Medical across 5 filings.
- Resonant Link Medical has filed 2 Form Ds with the SEC since 2024, most recently Apr 2025 ($3.4M sold to 7 investors).
- Status: Acquired/Merged (Operating Subsidiary).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Resonant Link Medical
Recorded secondary trades
No secondary trades in Resonant Link Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
1 filers · latest Apr 20261 SEC-registered fund reported 5 fair-value marks on Resonant Link Medical between Jan 2026 and Apr 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
1 roundsAbout Resonant Link Medical
Developer of multi-layer self-resonant structure designed to shatter the barriers of conventional wireless power. The company's structure uses coil technology to eliminate an expensive component in conventional wireless chargers and improves efficiency, increasing performance and at the same time decreasing the cost, enabling clients to increase the range and power of wireless chargers while simultaneously reducing the size, weight, and price.
- Sector
- Information Technology
- HQ
- Burlington, VT, United States
- Founded
- 2017
- Employees
- 18
- Website
- rlmedical.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)